Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance.
Many antibiotics inhibit bacterial growth by binding to the ribosome and interfering with protein biosynthesis. Macrolides represent one of the most successful classes of ribosome-targeting antibiotics. The main clinically-relevant mechanism of resistance to macrolides is dimethylation of the 23S rRNA nucleotide A2058 located in the drug binding site, a reaction catalyzed by the Erm-type rRNA-methyltransferases. Here, we present the crystal structure of the Erm-dimethylated 70S ribosome at 2.4\xc3\x85 resolution together with the structures of unmethylated 70S ribosome functional complexes alone and in combination with macrolides. Altogether, our structural data do not support the previous models and, instead, suggest a principally new explanation of how A2058-dimethylation confers resistance to macrolides. Moreover, high-resolution structures of two macrolide antibiotics bound to the unmodified ribosome revealed a previously unknown role of desosamine moiety in drug binding, laying a foundation for the rational knowledge-based design of macrolides that can overcome Erm-mediated resistance.
INTRODUCTION<!>Engineering of Erm-expressing T. thermophilus strain.<!>Structure of the 70S ribosome with m62A2058.<!>Deciphering the role of desosamine in macrolide binding.<!>Structural basis for Erm-mediated macrolide resistance.<!>DISCUSSION<!>Electron density maps of N6-dimethylated and unmethylated adenine residues in the current structure of the A2058-methylated Thermus thermophilus 70S ribosome.<!>Aminoacylated A- and P-site tRNAs bound to the A2058-methylated 70S ribosome.<!>Structural comparison of the ribosome-bound macrolides.<!>Analysis of the orientation of the dimethyl-amino group in previously published structures of ribosome-bound macrolides.<!>Electron density maps of ribosome-bound erythromycin and telithromycin.<!>In silico modeling of the A2058 mutants.<!>Alignment of the structures of A2058-methylated 70S ribosome with the ribosome-bound clindamycin or quinupristin.
<p>Antibiotics prevent bacterial growth by inhibition of vital cellular processes. Many of them target functionally important sites on the bacterial 70S ribosome and block protein synthesis1. Prominent among these inhibitors are macrolide antibiotics, a large family of natural and semi-synthetic compounds that consist of 12- to 16-membered macrolactone rings decorated with various side chains. Macrolides are widely used for the treatment of human community-acquired bacterial respiratory tract infections, including those that arise as complications of viral diseases2,3. These antibacterials achieve their inhibitory action by binding in the nascent peptide exit tunnel (NPET) of the bacterial ribosome and interfering with the progression of some growing polypeptides through this tunnel4. Several mechanisms of resistance to macrolides have been described, including efflux5,6, enzymatic degradation of the drugs7,8, or alteration of the drug-binding pocket through mutations6,9. However, the most abundant among bacterial pathogens and clinically most relevant mechanism of resistance against macrolides is based on mono- or dimethylation of the N6 position of a specific adenine residue (A2058) of the 23S rRNA (E. coli numbering of the nucleotides is used throughout) (Fig. 1a)10–12. The modification of this nucleotide located in the macrolide binding pocket in the NPET is catalyzed by the Erm-type rRNA methyltransferases13,14. Dimethylation, in particular, dramatically reduces the binding of the macrolides to the ribosome, rendering cells highly resistant to these drugs15,16. In addition to macrolides, the same modification confers resistance to two other structurally-unrelated classes of ribosome-targeting antibiotics, which also bind in the NPET, specifically lincosamides and streptogramins B (hence this type of resistance is known as MLSB)17.</p><p>Significant efforts have been invested in developing newer generations of semi-synthetic macrolide antibiotics with improved binding properties, e.g. ketolides2. These drugs show improved activity against a variety of Gram-positive and Gram-negative pathogens, including those carrying inducible erm genes3,18. Nevertheless, bacteria that constitutively express Erm-methyltransferase enzymes that dimethylate A2058 still demonstrate high levels of resistance to all the known macrolide antibiotics19,20. Therefore, there is a pressing demand for the development of new macrolides active against Erm-modified ribosomes of resistant pathogens. Understanding at a structural level the detailed molecular mechanism of Erm-mediated resistance to macrolides would provide key insights that are essential for the development of such compounds.</p><p>Previous attempts to explain the effect of A2058-methylation on drug binding were based on the structures of unmodified bacterial ribosomes complexed with various macrolides21–24. According to the prevailing steric clash model, the positions of the methyl group(s) added to the exocyclic N6 amino group of A2058 would overlap either with the 2´-hydroxyl group or the dimethyl-amino group of the desosamine sugar of a macrolide21. Due to this collision, the drug molecule should be unable to fully accommodate into its binding pocket and form hydrogen (H-) bond(s) with the A2058 and, therefore, cannot stably bind to the Erm-modified ribosome. However, the simplistic steric clash model is hard to be reconciled with the available experimental data. For instance, macrolide derivatives with 2´-deoxy or 3´-desmethyl desosamine, which were designed to reduce the steric clash with dimethylated A2058, were inactive against Staphylococcus aureus strains constitutively expressing Erm methyltransferase25. An alternative model is based on molecular dynamics simulation studies that suggest methylation of A2058 would result in complex structural rearrangements of the entire macrolide binding pocket, making drug binding impossible26. This model could rationalize the observed Erm-mediated resistance to all antibiotics of the MLSB group, macrolides, lincosamides, and streptogramins B, which bind at the overlapping sites within the NPET of the bacterial ribosome. Although an attractive hypothesis, such structural rearrangements have never been experimentally verified or observed structurally.</p><p>By finding the conditions for expressing functionally-active Erm-methyltransferase in thermophilic bacterium Thermus thermophilus and solving the structures of the Erm-modified (A2058-dimethylated) and unmethylated 70S ribosome in complex with mRNA and aminoacylated tRNAs alone and in combination with macrolides, we demonstrate that neither of these models is likely to be correct. Instead, we present a principally new explanation of how A2058-dimethylation confers resistance to macrolide antibiotics. Not only we uncovered the mechanism of Erm-mediated macrolide resistance, but also our high-resolution structures of two macrolide antibiotics bound to the unmodified ribosome revealed a previously unknown role of the universal desosamine side chain in drug binding. The newly understood mode of interaction of this macrolide's moiety with the ribosome provides pivotal information for the design of macrolides that can overcome Erm-mediated resistance.</p><!><p>Erm enzymes are expressed in a broad spectrum of pathogenic bacterial clinical isolates as well as in non-pathogenic native bacterial species where they produce strong resistance to macrolides27. The Erm methyltransferase operates during ribosome assembly because in the mature ribosome the target of Erm action, A2058 of the 23S rRNA, is inaccessible to the enzyme28. To obtain a structure of the Erm-modified ribosome, we have chosen the Gram-negative thermophilic bacterium T. thermophilus (Tth) as our experimental model because Tth ribosomes have been successfully used in the past for structure determination and produce the highest-resolution data29. However, our attempts to express a functionally active Erm enzyme PikR2 from the mesophilic bacterium Streptomyces venezuelae30 in this thermophilic host have failed, presumably due to protein instability at high growth temperature (Supplementary Table 1). To overcome this problem, we selected four erm-like genes from genomes of bacteria adapted for growth at elevated temperatures (Fig. 1b; Supplementary Figs. 1, 2; Supplementary Table 1). The genes were synthesized, cloned into the pBGAA1 vector31, and expressed in T. thermophilus (Fig. 1c). Macrolide susceptibility testing of the plasmid-transformed Tth cells showed that the expression of an erm-like gene from Bifidobacterium thermophilum (referred hereafter as ErmBth) resulted in a strong resistance to the macrolide antibiotic erythromycin (ERY), increasing the minimal inhibitory concentration (MICERY) for the ErmBth-expressing cells 1000-fold compared with the control cells carrying the empty vector (Supplementary Table 2).</p><p>To verify that the observed macrolide resistance results from the specific methyltransferase activity of ErmBth, we used a primer extension analysis to biochemically assess A2058 modification32. This method is based on the arrest of reverse transcriptase (RT) progression on the rRNA template due to its inability to incorporate a complementary nucleotide into the synthesized cDNA at the N6-dimethylated adenine. The expected cDNA arrest product of the RT reaction corresponding to the A2058 position was observed only on the 23S rRNA isolated from the Tth cells expressing ErmBth (Fig. 1d, lanes 2 and 3), confirming that ErmBth has the desired A2058-targeting methylation activity. Moreover, we found that the level of A2058-dimethylation can be significantly increased by growing the ErmBth-expressing cells in the presence of sub-inhibitory concentrations of ERY (Fig. 1d, e). By optimizing ERY concentration and growth temperature of the ErmBth-expressing T. thermophilus strain, we managed to reach the level of A2058 dimethylation as high as ~60% (Fig. 1e). Since X-ray crystallography is essentially an averaging technique, structural data could be confidently interpreted even if only half of the ribosomes are N6-dimethylated at A2058.</p><!><p>We used our T. thermophilus strain expressing ErmBth-methyltransferase to purify 70S ribosomes for structural analysis. These were crystallized using previously published conditions29 in a functional state that corresponds to a pre-peptide bond formation state of the ribosome, in which unreacted fMet-tRNAiMet (in the form of its non-hydrolyzable analog fMet-NH-tRNAiMet) occupies the P-site, while non-hydrolyzable Phe-NH-tRNAPhe is bound to the A-site. By applying our recent improvements in complex preparation (see Materials and Methods), we were able to obtain crystal structures of the A2058-dimethylated and unmethylated Tth 70S ribosome in complex with mRNA and aminoacylated tRNAs determined at 2.4Å and 2.5Å resolution, respectively (Supplementary Table 3). For a more accurate understanding of drug-ribosome interactions, we determined structures of the unmethylated ribosomal functional complexes bound with two macrolide antibiotics, telithromycin (TEL) or erythromycin (ERY). These structures have been solved at 2.6Å and 2.55Å resolution, respectively, and represent the highest resolution 70S ribosome-macrolide structures available to date (Supplementary Table 3).</p><p>At this resolution, methylation of nucleotide bases can be directly visualized in the unbiased electron density maps (Fig. 2a, green mesh), and the N6-dimethylated A2058 (m62A2058) can be confidently modeled in our structure (Fig. 2a, b; Extended Data Fig. 1a). Due to the presence of aminoacylated tRNAs (Extended Data Fig. 2), our structure of the WT ribosome with the unmodified A2058 reached a higher resolution than the previously reported structure33, and clearly shows the position and orientation of the unmethylated A2058 residue which, therefore, serves as our reference point (Fig. 2c, d). Additional evidence for the presence of the methyl groups on m62A2058 comes from the comparison of electron densities for the methylated m62A2058 and the unmethylated A2057 in the 23S rRNA (negative control, Extended Data Fig. 1b) or the N6-dimethylated A1519 in the 16S rRNA (positive control, Extended Data Fig. 1c) of the same structure. In contrast to the predictions of MD simulations that A2058 modification would lead to a dramatic rearrangement of the macrolide binding site26, no significant changes were observed in the orientations of the 23S rRNA nucleotides or the amino acid residues of the ribosomal proteins L4 and L22 neighboring A2058 in the ErmBth-modified ribosome (Fig. 3a, b). Most importantly, m62A2058 appears in the same orientation relative to its neighbors as compared to the reference (unmodified) structure (Fig. 3c, d). Because A2058 methylation has been proposed to cause long-range structural rearrangements and affect the functionality of the ribosome26, we also examined the ErmBth-modified ribosome for shifts in any of the key functional nucleotides around the PTC but failed to find any changes. Altogether our high-resolution structure of the A2058-dimethylated ribosome shows that the Erm-catalyzed rRNA modification does not cause any significant structural rearrangements in the macrolide binding site in the NPET.</p><p>Despite the fact that macrolide antibiotics have many H-bond donors and acceptors (Fig. 4a), there is only a single H-bond (between the 2´- OH of the desosamine sugar of a macrolide and the N1 atom of the A2058) that has been consistently observed in all previous structures of ribosome-bound macrolides (Fig. 4b)21–24,34–36. It has been suggested previously that the methyl groups of the N6-dimethylated A2058 residue can sterically clash with either the 2´-OH or the 3´-dimethyl-amino group of desosamine, leading to disruption of this critical H-bond and disturbing macrolide binding21,22. However, superposition of our structure of A2058-dimethylated Tth ribosome with that of the unmethylated Tth ribosome bound to ERY (or TEL) shows no overlap between the m62A2058 methyl groups and the desosamine 2´-OH (Fig. 4b, c) or the desosamine dimethyl-amino groups (Fig. 4b, d). It is important to point out that, because the N6-nitrogen of the N6-dimethylated (and also N6-monomethylated) adenine residue has sp2 geometry37, the two methyl groups attached to the exocyclic amine of m62A2058 are planar with the adenine heterocycle ring. Furthermore, the sp2 geometry of the N6-atom does not allow free rotation around the C6-N6 bond in m62A2058, excluding any alternative orientations of the methyl groups that could potentially result in a sterical clash with a macrolide. Thus, the analysis of the high-resolution structures of the ribosome-bound macrolides in complex with the unmodified ribosome and antibiotic-free A2058-dimethylated ribosome brings us to the conclusion that dimethylation of the exocyclic amine of A2058 by Erm methyltransferase does not result in a steric clash with desosamine sugar of the macrolide antibiotic or the loss of the H-bond between the desosamine 2´-OH and the A2058 residue proposed previously to explain Erm-mediated resistance to macrolides.</p><!><p>The dimethyl-amino group of desosamine has been shown previously to be crucial for the interaction of macrolides with the ribosome38. However, its exact role in drug binding has never been revealed. It is evident from the previous structural studies that no ribosomal component is directly involved in the interaction with this group. Moreover, by comparing all the available structures of ribosome-macrolide complexes, we noticed a significant variability in the orientation of this chemical group (Extended Data Figs. 3, 4), possibly due to varying interpretations of the electron density maps rather than differential placement of this chemical moiety. Notably, in none of the previous structures 3´-dimethyl-amino group of desosamine directly interacts with any of the ribosome counterparts.</p><p>In our 2.55Å and 2.6Å resolution structures of ribosome-bound ERY or TEL, both drug molecules are located in the canonical macrolide-binding pocket in the NPET near the PTC23,24,35. Interestingly, the shape of the electron density around the desosamine dimethyl-amino group clearly shows that the nitrogen lone pair of electrons (and this group as a whole) is pointed in the direction of A2058 (Fig. 5a, b, middle insets; Extended Data Fig. 5). This orientation is different from that in some of the previous structures, in which this group is oriented towards the exocyclic N6-amino group of the adjacent A2059 (Extended Data Fig. 4a,b)22–24,34–36. However, it resembles the orientation of this moiety in the 2.4Å-resolution structure of azithromycin bound to Haloarcula marismortui 50S ribosomal subunit (Extended Data Fig. 4c)22 or the 3.0Å- resolution structure of this macrolide bound to Tth 70S ribosome (Extended Data Fig. 4d)23.</p><p>Importantly, the high quality of the electron density maps of the new 70S-ERY and 70S-TEL structures allowed us to detect a distinct peak of positive electron density in close proximity to the dimethyl-amino moiety of desosamine in both complexes (Fig. 5a, b). We interpreted this electron density as a tightly coordinated water molecule based on the following criteria: (i) it fits snuggly between the two potential H-bond acceptors (nitrogen of the dimethyl-amino group of desosamine and one of the non-bridging oxygens of the G2505 phosphate) and a strong H-bond donor (exocyclic N6 amino group of the A2058); (ii) the distances between the aforementioned atoms and a putative water molecule in this location are all within the ideal range for H-bonds (2.5–3.5Å); (iii) the orientations of the proposed H-bonds correspond to the ideal tetrahedral geometry of the sp3-hybridized oxygen atom of a water molecule (Fig. 5a, b); (iv) ideal planar geometry with the heterocycle ring for the H-bond from the A2058 N6 donor to the oxygen acceptor of the modeled water (Fig. 5a, b, middle insets); (v) the observed electron density is too weak to be attributed to more electron-dense ions, such as Mg2+ or K+. Thus, because of the high resolution of our new 70S-ERY and 70S-TEL structures, it becomes evident that the high affinity of desosamine-containing macrolides to the ribosome is mediated by a strong H-bond mediated by the water molecule, which in turn is tightly coordinated by the exocyclic N6-amino group of A2058 and the phosphate of G2505 of 23S rRNA (Fig. 5c). This critical, water-mediated contact between a macrolide molecule and the ribosome, which has never been reported before, illuminates the previously obscure role of the dimethyl-amino moiety of desosamine in macrolide binding to the ribosome. Consistent with our observations, re-evaluation of the electron density maps of previously published ribosome-macrolide complex structures revealed the presence of this same water molecule; a peak of positive electron density can be seen in the same location in all structures with resolution ≤ 2.7Å22,34. However, it is the high quality of our structural data, which allows for interpretation of this density peak as a water molecule and reveals the possibly critical role of this, previously overlooked, player in macrolide binding.</p><!><p>The discovery of a key water molecule that mediates macrolide binding to the ribosome and the solved structure of the A2058-dimethylated ribosome allows a conceptually new rationalization of Erm-mediated macrolide resistance in molecular terms. In the unmethylated ribosome, the N6-amino group of the A2058 residue serves as an H-bond donor that shares one proton with the H2O oxygen atom (Fig. 5c, e). This water molecule, in turn, shares one of its protons with the G2505 phosphate and the other proton with the dimethyl-amino group of a macrolide. Dimethylation (but not monomethylation) of the N6-amino group of the A2058 by Erm-methyltransferases makes coordination of this water molecule impossible due to the inability of the A2058 dimethyl-amino group to serve as a proton donor. Furthermore, one of the m62A2058 methyl groups would physically displace the water molecule (Fig. 5d, e), leaving the dimethyl-amine of desosamine without the mediator of its interaction with the G2505 phosphate. The lack of such interaction in the A2058-dimethylated ribosome would have a strong negative effect on the free energy of the drug-ribosome complex leading to macrolide resistance. The same water molecule could also be observed in the current structure of wild-type ribosome in the absence of a macrolide. Therefore, it is conceivable that it could be important for normal ribosome functioning by stabilizing the local structure of the 23S rRNA. Displacement of this water molecule by dimethylation of A2058 and the resulting alteration in the local 23S rRNA structure and/or the chemical makeup of the NPET could potentially account for reduced fitness of cells expressing Erm methyltransferase, linked to aberrant translation of specific proteins39.</p><p>Besides the Erm-catalyzed dimethylation of A2058, mutations of this nucleotide to guanine, cytosine, or uracyl also result in macrolide resistance40,41. The discovered water-mediated interaction of macrolides with the ribosome allows re-evaluation of the mechanism of antibiotic resistance caused by these mutations (Extended Data Fig. 6a). In silico modeling of the A2058 mutations reveals that pyrimidine bases at this position would be placed too far from the desosamine moiety of a macrolide to establish any interactions with the drug (including water-mediated contacts) (Extended Data Fig. 6c, d). Replacing A2058 with guanine was proposed to lead to a steric clash with the C4 carbon of the macrolactone ring (Extended Data Fig. 6b)22. Our structures show that in addition to this mechanism, G2058 would not be able to coordinate the critical molecule of water the same way as adenine because the O6 atom of guanine cannot serve as an H-bond donor (Extended Data Fig. 6b).</p><p>Erm-mediated dimethylation of A2058 residue is the major clinical mechanism of bacterial resistance not only to macrolides but also to lincosamides and type B streptogramins. Comparison of our structure of the A2058-dimethylated 70S ribosome with the previously reported structure of the ribosome-bound lincosamide antibiotic clindamycin24 reveals a significant steric clash between one of the methyl groups of m62A2058 and the 2´- and 3´-OH groups of the 7-chloro-1-methylthio-lincosamine moiety of the drug (Extended Data Fig. 7a, b). In contrast to macrolides and type B streptogramins, a similar high level of resistance to lincosamides could be achieved not only by dimethylation but also by monomethylation of A205827,42. Due to the sp2 geometry of the N6-atom, the single methyl group of the monomethylated A2058 residue can exist in two alternative conformations: syn-methyl (with the methyl group oriented towards the Watson-Crick edge of the nucleotide) and anti-methyl (with the methyl group rotated towards the N7-atom of the adenine base)43. Importantly, it is only the syn-methyl conformation of the N6-methyl group of monomethylated A2058 that would clash with the ribosome-bound lincosamide drug, whereas the N6-methyl group in the anti-methyl conformation not only avoids the clash but could also retain all H-bonding capabilities potentially critical for the lincosamide drug binding (Extended Data Fig. 7b). However, because of a steric hindrance from the N7-atom of adenine, the syn-methyl conformation is energetically more favorable than the anti-methyl conformation43. Unlike macrolides, lincosamides, whose binding to the ribosome is characterized by 3-order of magnitude lower affinity44,45, apparently cannot overcome the energy needed to re-orient the methyl group of N6-monomethylated A2058 into unfavorable anti-methyl conformation. Thus, N6-monomethylation of the A2058 is likely to cause resistance to lincosamides via the same steric hindrance mechanism as the dimethylation of the same adenine residue (Extended Data Fig. 7a, b).</p><p>Interestingly, similar superpositioning of the structure of the A2058-dimethylated ribosome with the published structure of type B streptogramin antibiotic quinupristin complexed to the ribosome46 does not show any overlap between m62A2058 and the drug (Extended Data Fig. 7c, d). Moreover, the N6-dimethyl is located on the opposite side of the A2058 nucleotide relative to the closest dimethyl-amino-phenylalanine moiety of the ribosome-bound quinupristin (Extended Data Fig. 7d). This moiety likely forms a Van-der-Waals contact with the N3 atom of the A2058 residue. However, because the A2058 nucleotides in the two superimposed structures have the same conformations, the N6-dimethylation of A2058 is unlikely to perturb this contact (Extended Data Fig. 7d). Overall, structural analysis shown in Extended Data Fig. 7c does not reveal disruptions of any critical contacts of the drug with the ribosome that could be caused by Erm-catalyzed A2058 dimethylation and, thus, does not offer a straightforward explanation for the molecular mechanism of the Erm-mediated streptogramin B resistance, which still remains enigmatic. Although Erm-mediated dimethylation of A2058 renders bacterial ribosomes resistant to macrolides, lincosamides, and streptogramins B, the actual mechanism of resistance at a molecular level appears to be different for each class of NPET-targeting antibiotics.</p><!><p>Our work was motivated by the lack of understanding of why Erm-mediated dimethylation of the 23S rRNA residue A2058, located in the macrolide binding site, confers resistance to macrolide antibiotics. The high-resolution structures of two macrolides bound to the sensitive ribosomes and the first structure of the A2058-dimethylated 70S ribosome provided critical clues that allowed us to propose a model that offers a likely explanation of how this mechanism of resistance actually operates. The discovery of a previously cryptic water molecule that appears to be playing a pivotal role in macrolide binding clarified the importance of interactions of the desosamine group of the drug with the ribosomal target. The other key breakthrough came from optimizing the expression of Erm-methyltransferase encoded in the genome of a moderate bacterial thermophile B. thermophilum in the highly thermophilic bacterial host T. thermophilus. This permitted us to prepare the crystallizable 70S ribosomes with a highly methylated A2058 residue. The revealed placement of methyl groups appended to the exocyclic N6-amino group of A2058 showed that the water-mediated bridging becomes impossible in the Erm-modified ribosome, which likely leads to the reduced affinity of the macrolide drugs that rely on this contact.</p><p>Altogether, our structural study uncovering the molecular mechanism of Erm-mediated resistance could be a starting point for the rational knowledge-based development of new MLSB antibiotics active against challenging drug-resistant pathogens. This quest will be likely additionally stimulated by the recently discovered new combinatorial approaches for the synthesis of novel macrolides47, streptogramins48, and other drugs. Interestingly, all previous attempts to make macrolides active against Erm-modified ribosomes relied on derivatization of the existing macrolides to provide additional anchoring points that improved their overall affinity49. However, none of the derivatizations affected the desosamine likely due to its importance in overall drug binding. Unfortunately, the affinities of the resulting semi-synthetic macrolides of a newer generation (such as telithromycin or solithromycin) to the modified ribosome are too low to allow using these drugs for the treatment of infections caused by pathogens with expressed erm genes2,19,50. Now, when the precise role of the desosamine sugar in macrolide binding to the ribosome is uncovered, this information may become instrumental in the designing of macrolides that can overcome Erm-mediated resistance.</p><!><p>(a, b, c) Unbiased Fo-Fc (top row; grey and green mesh) and 2Fo-Fc (bottom row; blue mesh) electron density maps corresponding to the (a) N6-dimethylated A2058 residue, or (b) the unmethylated A2057 residue of the 23S rRNA, or (c) N6-dimethylated A1519 residue of the 16S rRNA (naturally modified by methyltransferase KsgA) in the T. thermophilus 70S ribosome contoured at 3.0σ and 1.0σ, respectively. The refined models are displayed in the corresponding electron density maps. Carbon atoms are colored blue for the methylated A2058, light blue for the unmethylated A2058, and pale yellow for the methylated A1519. Nitrogens are colored dark blue; oxygens are red, phosphorus atoms are green. Grey mesh shows the Fo-Fc map after refinement with the entire modified nucleotide omitted. Green mesh shows the Fo-Fc electron density map after refinement with the nucleotides A2058 and A1519 built as regular unmethylated adenines. We show electron density maps for the A2057 and the A1519 nucleotides as negative and positive control references originating from the same structure.</p><!><p>(a, b, c) High-resolution (2.4Å) 2Fo-Fc electron density map (blue mesh) for the ribosome-bound A-site Phe-NH-tRNAPhe (green) and the P-site fMet-NH-tRNAiMet (dark blue). The refined models of tRNAs are displayed in their respective electron density map contoured at 1.2σ. (a) The entire bodies of the A- and P-site tRNAs viewed from the back of the 50S subunit, as indicated by the inset. Ribosome subunits are omitted for clarity. (b, c) Close-up views of the tRNA CCA-ends carrying phenylalanyl (magenta) and formyl-methionyl (blue) moieties. Nitrogens are colored blue; oxygens are red, sulfur is yellow. In (B), H-bond between the α-amino group and the 2'-OH of the A76 of the P-site tRNA is shown with the black dotted line. This H-bond is pivotal to optimally orient α-amine for an in-line nucleophilic attack onto the carbonyl carbon of the P-site substrate. (d) Superimposed models of aminoacylated tRNAs from the current 2.4Å structure of A2058-methylate 70S ribosome with the previous 2.6Å structure of A2058-unmethylated ribosome (PDB entry 1VY433).</p><!><p>(a) Superpositioning of the structures of ERY in complex with the 70S ribosomes from T. thermophilus (teal, PDB entry 6ND635; green, PDB entry 4V7X23), E. coli (yellow, PDB entry 4V7U24), or H. marismortui (blue, PDB entry 1YI222). (b) Superpositioning of the structures of the 50S ribosomal subunit from H. marismortui in complex with ERY (blue, PDB entry 1YI222), azithromycin (AZI, orange, PDB entry 1YHQ22), and telithromycin (TEL, magenta, PDB entry 1YIJ22). (c) Superpositioning of the structures of the 70S ribosome from T. thermophilus in complex with ERY (green, PDB entry 4V7X23), azithromycin (AZI, orange, PDB entry 4V7Y23), and telithromycin (TEL, magenta, PDB entry 4V7Z23). The insets show closed up views of the desosamine sugar. Note a significant variability in the orientation of the dimethylamino groups of the desoamine sugar among ribosome-bound macrolides.</p><!><p>a, b) In the structures of erythromycin (ERY) in complex with H. marismortui 50S subunit (blue, PDB entry 1YI222), or T. thermophilus 70S ribosome (green, PDB entry 4V7X23) the nitrogen lone pair of electrons on the dimethyl-amino group of the desosamine sugar is oriented towards the exocyclic N6-amino group of the A2059 nucleotide of the 23S rRNA (blue), as indicated by the yellow arrow. Note that the formation of a direct H-bond, in this case, is impossible due to the large distance between the potential interacting partners (grey dashed lines). H-bond between 2'-OH group of desosamine sugar and N1 atom of A2058 is shown by the black dashed lines. (c, d) In the structures of azithromycin (AZI) in complex with H. marismortui 50S subunit (orange, PDB entry 1YHQ22), or T. thermophilus 70S ribosome (orange, PDB entry 4V7Y23) the nitrogen lone pair of electrons of the dimethyl-amino group on the desosamine is rotated by approximately 90 degrees away from the residue A2059 in the direction of residue A2058, as indicated by the yellow arrow. Note that, in this case, there are no obvious binding partners for this group on the ribosome.</p><!><p>(a, c) Chemical structures of NPET-binding macrolide antibiotics erythromycin (a, ERY) and telithromycin (c, TEL). (b, d) High-resolution 2Fo-Fc electron density maps (blue mesh) of ERY (b, green) and TEL (d, magenta) in complex with the T. thermophilus 70S ribosome viewed from two different perspectives. The refined models of ERY or TEL are displayed in their respective electron densities contoured at 1.0σ. Nitrogen atoms are colored blue; oxygens are red. Key chemical moieties of each drug are labeled.</p><!><p>(a) Water-mediated coordination of a macrolide antibiotic (ERY, green) by the wild-type A2058 nucleotide (blue) of the 23S rRNA. Existing H-bonds are shown by the black dashed lines. (b, c, d) Strong water-mediated coordination of a macrolide molecule on the ribosome becomes impossible when the adenine nucleotide at position 2058 of the 23S rRNA is mutated to guanine (b), cytosine (c), or uracil (d) nucleotides. Non-existing H-bonds (due to distance restraints) are shown by the grey dashed lines. Note that in the case of A2058G mutation, in addition to the inability of the guanine nucleotide to coordinate a macrolide via a water molecule, the exocyclic N2-amino group of guanine clashes with the C4-methyl group attached to the macrolactone ring of a macrolide molecule.</p><!><p>Superposition of the current structure of A2058-methylated 70S ribosome with the structure of ribosome-bound lincosamide antibiotic clindamycin (yellow, PDB entry 4V7V24) (a, b) or streptogramin type B antibiotic quinupristin (teal, PDB entry 4U2646) (c, d). Nucleotides of the Erm-modified and unmodified ribosomes are shown in blue and light blue, respectively. Methylated A2058 residue is shown in blue with the methyl groups highlighted in orange. All structures were aligned based on domain V of the 23S rRNA.</p>